Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P20908: Variant p.Gly530Ser

Collagen alpha-1(V) chain
Gene: COL5A1
Feedback?
Variant information Variant position: help 530 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Glycine (G) to Serine (S) at position 530 (G530S, p.Gly530Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In EDSCL1. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 530 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1838 The length of the canonical sequence.
Location on the sequence: help DGLPGPPGTMLMLPFRFGGG G DAGSKGPMVSAQESQAQAIL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         DGLPGPPGTMLMLPFRFGGGGDAGSKGPMVSAQESQAQAIL

Mouse                         DGLPGPPGTMLMLPFRFGGGGDAGSKGPMVSAQESQAQAIL

Rat                           DGLPGPPGTMLMLPFRFGGGGDAGSKGPMVSAQESQAQAIL

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 38 – 1605 Collagen alpha-1(V) chain
Region 444 – 558 Interrupted collagenous region
Region 526 – 545 Disordered



Literature citations
Compound heterozygosity for a disease-causing G1489E and disease-modifying G530S substitution in COL5A1 of a patient with the classical type of Ehlers-Danlos syndrome: an explanation of intrafamilial variability?
Giunta C.; Steinmann B.;
Am. J. Med. Genet. 90:72-79(2000)
Cited for: VARIANTS EDSCL1 SER-530 AND ASP-1489; Homozygous Gly530Ser substitution in COL5A1 causes mild classical Ehlers-Danlos syndrome.
Giunta C.; Nuytinck L.; Raghunath M.; Hausser I.; De Paepe A.; Steinmann B.;
Am. J. Med. Genet. 109:284-290(2002)
Cited for: VARIANT EDSCL1 SER-530; The molecular basis of classic Ehlers-Danlos syndrome: a comprehensive study of biochemical and molecular findings in 48 unrelated patients.
Malfait F.; Coucke P.; Symoens S.; Loeys B.; Nuytinck L.; De Paepe A.;
Hum. Mutat. 25:28-37(2005)
Cited for: VARIANTS EDSCL1 SER-530 AND CYS-1486; VARIANTS ASP-114; ASN-192 AND SER-951;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.